John B. Moriarty
General Counsel, Alexion Pharmaceuticals.
Companies
- Kardigan, Inc.General counsel Jun 18, 2026 to now1
- Avidity Biosciences, Inc.General counsel Aug 5, 2024 to now2
- Mirati Therapeutics, Inc.General counsel Jun 23, 2023 to Jan 23, 20243
- Olema Pharmaceuticals, Inc.EVP, Ch. Legal Officer & Sec. Nov 18, 2020 to Feb 2, 20234
- Alexion PharmaceuticalsGeneral counsel Dec 18, 2012 to Feb 8, 20185
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Kardigan, Inc. KARD47,784 shares6$663.2K at $13.88Jun 17, 2026
- Mirati Therapeutics, Inc.0 shares7Jan 23, 2024
- Avidity Biosciences, Inc.0 shares8Feb 27, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 17, 2026Granted 47,784 shares of Kardigan, Inc.6
- Feb 27, 2026Returned to company 92,054 shares of Avidity Biosciences, Inc.8
- Jan 7, 2026Sold 2,374 shares at $72.23 of Avidity Biosciences, Inc.9
- Dec 17, 2025Shares withheld for tax 26,824 shares at $71.87 of Avidity Biosciences, Inc.10
- Dec 17, 2025Granted 56,000 shares of Avidity Biosciences, Inc.10
- Aug 4, 2025Sold 2,245 shares at $36.21 of Avidity Biosciences, Inc.11
- Jan 6, 2025Granted 25,000 shares of Avidity Biosciences, Inc.12
- Aug 1, 2024Granted 25,000 shares of Avidity Biosciences, Inc.13
- Jan 23, 2024Returned to company 71,660 shares of Mirati Therapeutics, Inc.7
- Jan 23, 2024Returned to company 675 shares of Mirati Therapeutics, Inc.7
- Aug 9, 2023Granted 22,297 shares at $37.00 of Mirati Therapeutics, Inc.14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARKardigan, Inc., General counsel
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jan 9, 2026
- 10SEC EDGARForm 4 filed Dec 19, 2025
- 11SEC EDGARForm 4 filed Aug 5, 2025
- 12SEC EDGARForm 4 filed Jan 8, 2025
- 13SEC EDGARForm 4 filed Aug 5, 2024
- 14SEC EDGARForm 4 filed Aug 10, 2023